BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37315950)

  • 1. Drug-Eluting Porous Embolic Microspheres for Trans-Arterial Delivery of Dual Synergistic Anticancer Therapy for the Treatment of Liver Cancer.
    Amoyav B; Bloom AI; Goldstein Y; Miller R; Sharam M; Fluksman A; Benny O
    Adv Healthc Mater; 2023 Dec; 12(30):e2301548. PubMed ID: 37315950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma.
    Chen M; Shu G; Lv X; Xu X; Lu C; Qiao E; Fang S; Shen L; Zhang N; Wang J; Chen C; Song J; Liu Z; Du Y; Ji J
    Biomaterials; 2022 May; 284():121512. PubMed ID: 35405577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tirapazamine-loaded CalliSpheres microspheres enhance synergy between tirapazamine and embolization against liver cancer in an animal model.
    Li Q; Liu Y; Guo X; Zhang L; Li L; Zhao D; Zhang X; Hong W; Zheng C; Liang B
    Biomed Pharmacother; 2022 Jul; 151():113123. PubMed ID: 35594702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere.
    Ma P; Chen J; Qu H; Li Y; Li X; Tang X; Song Z; Xin H; Zhang J; Nai J; Li Z; Wang Z
    Drug Deliv; 2020 Dec; 27(1):1412-1424. PubMed ID: 33096947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
    Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
    Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cirrhotic hepatocellular carcinoma-based decellularized liver cancer model for local chemoembolization evaluation.
    Wang M; Gao Y; Liu X; Li Z; Xiao J; Gao X; Gibson MI; Guo Q
    Acta Biomater; 2024 Mar; 176():144-155. PubMed ID: 38244660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas generating microspheres for immediate release of Hsp90 inhibitor aiming at postembolization hypoxia in transarterial chemoembolization therapy of hepatocellular carcinoma.
    Choi JW; Lee SY; Cho EJ; Jeong DI; Kim DD; Kim HC; Cho HJ
    Int J Pharm; 2021 Sep; 607():120988. PubMed ID: 34389420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monodisperse CaCO
    Chen M; Guo X; Shen L; Ding J; Yu J; Chen X; Wu F; Tu J; Zhao Z; Nakajima M; Song J; Shu G; Ji J
    Int J Biol Macromol; 2023 Mar; 231():123160. PubMed ID: 36610575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice.
    Lin WH; Yeh SH; Yeh KH; Chen KW; Cheng YW; Su TH; Jao P; Ni LC; Chen PJ; Chen DS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11937-11942. PubMed ID: 27702890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of ion-exchange porous polyvinyl alcohol microspheres as a potential drug delivery embolization system.
    Li X; Ji X; Chen K; Yuan X; Lei Z; Ullah MW; Xiao J; Yang G
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111889. PubMed ID: 33579501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodic mesoporous organosilica-coated magnetite nanoparticles combined with lipiodol for transcatheter arterial chemoembolization to inhibit the progression of liver cancer.
    Liu L; Xu X; Liang X; Zhang X; Wen J; Chen K; Su X; Ma Y; Teng Z; Lu G; Xu J
    J Colloid Interface Sci; 2021 Jun; 591():211-220. PubMed ID: 33609893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of Sorafenib-eluting Microspheres to Enhance Therapeutic Efficacy of Transcatheter Arterial Chemoembolization in a Rat Model of Hepatocellular Carcinoma.
    Park W; Cho S; Ji J; Lewandowski RJ; Larson AC; Kim DH
    Radiol Imaging Cancer; 2021 Jan; 3(1):e200006. PubMed ID: 33575658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biodegradable multifunctional porous microsphere composed of carrageenan for promoting imageable trans-arterial chemoembolization.
    Kunliang L; Zhicheng J; Xiaolong H; Dan Y; Yu Z; Haidong Z; Gaojun T; Fei X
    Int J Biol Macromol; 2020 Jan; 142():866-878. PubMed ID: 31622716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib-Encapsulated Liposomes to Activate Hypoxia-Sensitive Tirapazamine for Synergistic Chemotherapy of Hepatocellular Carcinoma.
    Zhao J; Dai W; Zhan L; Lei L; Jin Q; Wang J; Tang Z
    ACS Appl Mater Interfaces; 2024 Mar; 16(9):11289-11304. PubMed ID: 38393963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.
    Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH
    Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor.
    Choi JW; Park JH; Baek SY; Kim DD; Kim HC; Cho HJ
    Colloids Surf B Biointerfaces; 2015 Aug; 132():305-12. PubMed ID: 26057730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-activated cascade nanovaccine for synergistic chemoembolization-immune therapy of hepatocellular carcinoma.
    Shi Q; Zhang W; Zhou Y; Huang S; Yu J; Yang M; Zhang Z; Ma J; Luo J; Rao S; Lu D; Peng S; Cao Y; Liu L; Yan Z
    Biomaterials; 2024 Apr; 306():122480. PubMed ID: 38271787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs.
    Megías Vericat JE; García Marcos R; López Briz E; Gómez Muñoz F; Ramos Ruiz J; Martínez Rodrigo JJ; Poveda Andrés JL
    Radiologia; 2015; 57(6):496-504. PubMed ID: 25857250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Zheng Z; Ma M; Han X; Li X; Huang J; Zhao Y; Liu H; Kang J; Kong X; Sun G; Sun G; Kong J; Tang W; Shao G; Xiong F; Song J
    Acta Biomater; 2023 Feb; 157():337-351. PubMed ID: 36509402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
    Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK
    AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.